Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine and Fentanyl for Acute Pain in the ED
NCT03959852Phase 4Terminated
- Sponsor
- Mercy
- Start
- Nov 2019
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ketamine in acute pain (3 arms), sponsored by Mercy. Primary endpoints: Analgesia of combination fentanyl and SDK as assessed using the pain scale 1-10, Analgesia of fentanyl as assessed using the pain scale 1-10 and 1 more. Started Nov 2019; status: terminated.
02
Drugs
ketamine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT03959852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03959852.